Aehr Test Systems (NASDAQ:AEHR) Director Howard Slayen Sells 25,000 Shares of Stock

Aehr Test Systems (NASDAQ:AEHR) Director Howard Slayen sold 25,000 shares of the company’s stock in a transaction on Friday, April 17th. The shares were sold at an average price of $85.00, for a total value of $2,125,000.00. Following the completion of the transaction, the director directly owned 178,328 shares in the company, valued at $15,157,880. This trade represents a 12.30% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Aehr Test Systems Stock Up 3.7%

Shares of Aehr Test Systems stock opened at $83.86 on Friday. The stock’s fifty day moving average is $42.81 and its two-hundred day moving average is $31.03. The company has a market capitalization of $2.64 billion, a PE ratio of -220.68 and a beta of 2.28. Aehr Test Systems has a 52 week low of $7.71 and a 52 week high of $91.43.

Aehr Test Systems (NASDAQ:AEHR) last issued its earnings results on Tuesday, April 7th. The semiconductor company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.02. Aehr Test Systems had a negative return on equity of 7.15% and a negative net margin of 25.23%.The business had revenue of $10.31 million during the quarter, compared to analysts’ expectations of $10.85 million. As a group, research analysts anticipate that Aehr Test Systems will post 0.1 earnings per share for the current year.

More Aehr Test Systems News

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Record $41M hyperscale AI production order — the follow‑on order is for package‑level burn‑in of custom AI ASICs and is described as the largest in company history, providing a clear near‑term revenue and capacity catalyst. Accesswire: Record $41M order
• Positive Sentiment: Bookings/backlog strength tied to AI/data‑center demand — company updates and coverage report second‑half bookings exceeding ~$92M and a record backlog, supporting upside to FY2027 revenue if orders convert. Benzinga: record deal & bookings
• Positive Sentiment: Analyst optimism and higher price targets — recent upgrades and bumped targets have reinforced investor interest and helped attract institutional/retail flows. MSN: price target increase
• Positive Sentiment: Technical/momentum factors may amplify moves — a recent golden‑cross and elevated short interest increase the likelihood of follow‑through and short covering when positive headlines arrive. Seeking Alpha: movers summary
• Neutral Sentiment: Volatility and coverage: several outlets note extreme YTD moves (one headline cites a 300% move) — useful as context for sentiment but not a direct fundamental change. InsiderMonkey: AEHR up 300%
• Neutral Sentiment: Mixed quarterly fundamentals — AEHR beat EPS slightly but missed revenue; execution to convert large bookings into sustained, profitable growth remains the key risk. MarketBeat: quarterly results
• Negative Sentiment: Clustered insider selling — multiple executives and directors disclosed sizable share sales (including director and C‑suite transactions in mid‑April), which can create near‑term selling pressure and raise investor questions about insider conviction. InsiderTrades: insider selling
• Negative Sentiment: Media and aggregation highlight insider liquidity events — coverage emphasizing millions in insider proceeds can weigh on sentiment even if some sales are routine or for tax purposes. TipRanks: insider sell-off

Institutional Investors Weigh In On Aehr Test Systems

Hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its stake in shares of Aehr Test Systems by 2.9% during the 3rd quarter. Vanguard Group Inc. now owns 2,288,190 shares of the semiconductor company’s stock worth $68,897,000 after purchasing an additional 65,444 shares during the last quarter. KLCM Advisors Inc. lifted its stake in shares of Aehr Test Systems by 200.0% during the 3rd quarter. KLCM Advisors Inc. now owns 75,000 shares of the semiconductor company’s stock worth $2,258,000 after purchasing an additional 50,000 shares during the last quarter. HighTower Advisors LLC lifted its stake in shares of Aehr Test Systems by 485.1% during the 3rd quarter. HighTower Advisors LLC now owns 78,340 shares of the semiconductor company’s stock worth $2,359,000 after purchasing an additional 64,950 shares during the last quarter. William Blair Investment Management LLC purchased a new stake in shares of Aehr Test Systems during the 3rd quarter worth $26,920,000. Finally, Fortitude Advisory Group L.L.C. purchased a new stake in shares of Aehr Test Systems during the 3rd quarter worth $671,000. 69.69% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

AEHR has been the subject of several research reports. Weiss Ratings reiterated a “sell (d)” rating on shares of Aehr Test Systems in a report on Wednesday, January 21st. William Blair upgraded Aehr Test Systems from a “market perform” rating to an “outperform” rating in a report on Monday, March 2nd. Lake Street Capital reiterated a “buy” rating on shares of Aehr Test Systems in a report on Wednesday, April 8th. Craig Hallum upgraded Aehr Test Systems from a “hold” rating to a “buy” rating and set a $68.00 target price for the company in a report on Wednesday, April 8th. Finally, Wall Street Zen upgraded Aehr Test Systems from a “strong sell” rating to a “sell” rating in a report on Saturday, April 11th. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $68.00.

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.